Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC

Publisher： Karger

E-ISSN： 1423-0232|89|1|53-59

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.1, 2015-02, pp. : 53-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer

By Nuijten Mark J.C.   Aultman Rick   Carpeño Javier de Castro   Vergnenègre Alain   Chouaid Christos   Walzer Stefan   Siebert Uwe  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2193-2201

Informa Healthcare

Access to resources Recommend Favorite

Genomic profiling of intestinal‐type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 2, 2018-02 ,pp. : 259-273

John Wiley & Sons Inc

Access to resources Recommend Favorite

Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6

By  

ALLERGY, Vol. 105-4538, Iss. 10, 2015-10 ,pp. : 1278-1287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6

By  

ALLERGY, Vol. 70, Iss. 10, 2015-10 ,pp. : 1278-1287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 296-301

Karger

Access to resources Recommend Favorite